deCODE chemistry
2501 Davey Road
Woodridge
Illinois
60517
United States
Tel: 630-783-4600
Fax: 630-783-4909
Website: http://www.decodechembio.com/
About deCODE chemistry
The integrated service offerings of deCODE chemistry and deCODE biostructures provide a unique and comprehensive approach to drug discovery and development outsourcing. deCODE biostructures services span from computer-aided design of expression-optimized synthetic gene constructs to protein expression and ligand bound co-crystal structure determination for purposes of structure based drug design. Capabilities of deCODE chemistry include lead discovery and optimization, development of scalable synthetic routes, custom synthesis of API and intermediates, cGMP production of materials for pre-clinical and clinical studies, and pre-formulation screening. The combined value is that deCODE provides a complete solution for discovering and developing optimized clinical candidates in a time efficient manner. Flexible business terms allow for tailored projects on a fee-for-service basis, or as part of a more substantial collaboration. deCODE’s facilities, located in Woodridge, IL and Bainbridge Island, WA, total over 150,000 sq ft. of multi-disciplinary laboratory space outfitted with state-of-the-art equipment and world-class scientists.
Last Updated: 08-01-2006
8 articles about deCODE chemistry
-
deCODE chemistry And deCODE biostructures: Fragments of Life – Enhancing Efficiency in Drug Discovery
7/24/2009
-
deCODE chemistry & deCODE biostructures and UCB, Inc. Announce a Collaboration to Discover and Develop Novel Anti-Inflammatory Drugs
2/9/2009
-
deCODE chemistry Release: Structure of a New Antibiotic Drug Target Revealed
1/5/2009
-
Families Of Spinal Muscular Atrophy, Invitrogen Corporation, And deCODE biostructures And deCODE chemistry Release: Protein Linked to Spinal Muscular Atrophy Identified
10/9/2008
-
Alex Kiselyov Joins deCODE biostructures as President; Lance Stewart Appointed President of deCODE biostructures
7/2/2007
-
deCODE chemistry Initiates Chemical Development Collaboration with SGX Pharmaceuticals, Inc.
6/14/2007
-
deCODE chemistry Initiates Chemical Development Collaboration with PolyMedix Inc. for Multiple Pre-clinical Candidates
6/13/2007
-
deCODE chemistry Expands Process Chemistry Relationship with Anacor Pharmaceuticals, Inc.
6/13/2007